Xylem INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
Xylem reported record 2025 results and asked shareholders to elect nine directors, ratify Deloitte, approve executive pay, and adopt a 2026 Employee Stock Purchase Plan ahead of its May 14, 2026 virtual annual meeting.
NYSE
Xylem Inc. will hold its annual meeting on May 13, 2025, where shareholders will vote on the election of directors, ratification of the auditor, executive compensation, and a shareholder proposal regarding special meetings.
NYSE
Xylem Inc. announces record revenue, profitability, and earnings per share for 2024, driven by the Evoqua acquisition and strategic operational improvements.
NYSE
Xylem Inc. is holding its annual shareholder meeting on May 16, 2024, to vote on the election of directors, ratification of auditors, and executive compensation.
NYSE
Xylem Inc.'s 2024 proxy statement highlights a transformational year marked by the acquisition of Evoqua, leadership changes, and strong financial performance, setting the stage for future growth and impact.